Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading iBio, Inc. chart...

About the Company

We do not have any company description for iBio, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

117

Exchange

NYSE

$0M

Total Revenue

117

Employees

$6M

Market Capitalization

-0.21

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IBIO News

Micro-Cap Stock iBio Doubles On Wednesday - Here's Why

23d ago, source: Hosted on MSN

iBio Inc (NYSE:IBIO) shares are surging after the company entered into a collaboration agreement with AstralBio Inc. on Wednesday to discover, engineer, and develop antibodies to treat obesity and ...

iBio Announces $15.0 Million Private Placement

24d ago, source: Business Insider

Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an ...

iBio Inc IBIO

7d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Why Has iBio Inc (AMEX: IBIO) Declined So Much?

12d ago, source:

iBio Inc (AMEX:IBIO) traded at $2.11 at close of the session on Friday, April 05, made a downward move of -15.26% on its previous day’s price.

IBio In Partnership With AstralBio; Shares Up In Pre-market

24d ago, source: Business Insider

(RTTNews) - iBio, Inc. (IBIO) Wednesday announced partnership with AstralBio, Inc. to develop novel antibodies to treat obesity and other cardiometabolic conditions. iBio shares were up more than ...

iBio Announces Reverse Stock Split

22d ago, source: ADVFN

iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) today announced that its Board of Directors has approved a 20-to-1 reverse split of the Company’s common stock, par value $0.001 per ...

iBio Announces $15.0 Million Private Placement

25d ago, source: Yahoo Finance

BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announces ...

iBio Inc

5d ago, source: U.S. News & World Report

What Is a Stock Market Correction? Investors may be shaken by a drop of 10% or more in a stock market index, but corrections are par for the course.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...